Tocagen Inc (NASDAQ:TOCA) Sellers Rose Their Shorts By 5.06%

June 27, 2018 - By Ronnie Lemelle

Tocagen Inc (NASDAQ:TOCA) had an increase of its short interest by 5.06%. FINRA issued short interest of TOCA’s total 1.07 million shares. That’s 5.06% up from 1.02M shares. Tocagen Inc (NASDAQ:TOCA) has 105,200 shares average volume. It’ll cost 10 days for TOCA to recover its previous position. Tocagen Inc float short is 7.15%.

TOCA is hitting $8.81 during the last trading session, after increased 3.28%.Tocagen Inc. has 189,655 shares volume, 66.53% up from normal. TOCA is downtrending and has moved 44.41% since June 27, 2017. TOCA underperformed the S&P 500 by 56.98%.

Tocagen Inc., a clinical-stage cancer-selective gene therapy company, focuses on developing and commercializing product candidates designed to activate a patient's immune system against their cancer.The firm is worth $175.43 million. The Company’s cancer-selective gene therapy platform is built on retroviral replicating vectors , which are designed to deliver therapeutic genes into the DNA of cancer cells.Currently it has negative earnings. The company??s lead product candidate is Toca 511 & Toca FC that is in Phase 2 portion of a randomized, controlled Phase 2/3 clinical trial for patients with recurrent high grade glioma (HGG).

Another two news for Tocagen Inc. (NASDAQ:TOCA) were briefly announced by: Benzinga.com on June 26, 2018 with title “Benzinga’s Daily Biotech Pulse: Epidiolex, Roche’s Influenza Drug Gets Priority Review Status, Xeris Jumps On …”. The other Benzinga.com‘s article was titled “26 Stocks Moving In Tuesday’s Pre-Market Session” and announced on June 26, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.